NCT04616924 — "RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease" trial site landscape

Public-registry site landscape for NCT04616924, “RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease”, a Pulmonary Mycobacterium Avium Complex Infection study sponsored by RedHill Biopharma Limited. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT04616924 (registry record)
Study title	RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease
Official title	Study of RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease in Adults With Nodular Bronchiectasis (CleaR-MAC Trial)
Sponsor	RedHill Biopharma Limited
Condition(s)	Pulmonary Mycobacterium Avium Complex Infection; Bronchiectasis; Lung Diseases
Phase	PHASE3
Listed sites	25
Site countries	United States

Patient-friendly overview of this study: eichor.com/study/NCT04616924.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT04616924 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →